The company has its presence in Australia, Brazil, Africa, India, Israel, Italy, Japan, Korea, Mexico, Poland, Spain, and Taiwan through its distributors. The company provides next generation sequencing products under diagnostics and genomics business segment. Incorporated in 2000 and headquartered at California, U.S.; Pacific Biosciences of California, Inc. is a manufacturer of sequencing systems and products to enable de novo genome assembly for identification, annotation and deciphering of genomic structures. Our experienced NGS specialists help you along the way to find the right service for your project. Incorporated in 1998 and headquartered at California, U.S.; Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The next-generation sequencing (NGS) market is expected to grow to USD 24 billion by 2025. RNA sequencing, with applications in human, plants & animals, and microbial research. Under this segment, the company offers instruments, reagents, assay platforms, and software to help in testing and screening of genetic abnormalities. The company uses the SBS technology to provide NGS services to its customers. The regulatory and reimbursement outlook for NGS has improved considerably in recent years, which also serves to boost the adoption of sequencing technologies among a wider user base. The report includes market specific company profiles of all 20 players and assesses the recent developments that shape the competitive landscape of this highly fragmented market. Would you believe there are next-gen sequencing technology companies other than the big players; Illumina, Life Technologies, Roche (454), PacBio, and Oxford Nanopore Technologies? The company also offers a technologically advanced Some are niche life science companies, while others are large multinational corporations. As a result, the use of distributors is generally limited to geographic regions where the company has no direct sales force. Quickly find next-generation sequencing and bioinformatics services from our network of over 100 partnering providers. The company provides next generation sequencing under Life Science business segment. Founded in 2005 and headquartered at England, U.K.; Oxford Nanopore Technologies Ltd is a developer of disruptive, electronic, single-molecule sensing system based on nanopore science. View top Next-Generation Sequencing (NGS) Services Vendors 360 quadrants to know the market leader. Incorporated in 1984 and headquartered at Venlo, Netherlands; Qiagen N.V. is engaged in transforming biological samples into molecular insights. Which of the following NGS services do you offer? The company operates through two business segments namely, Life Science and Clinical Diagnostics. However, they do not have very strong growth strategies for their overall business, when compared with the visionary leaders. QIAGEN N.V. provides its workflow to customers in molecular diagnostics, assay technologies, bioinformatics and automation systems. Massive parallel sequencing or massively parallel sequencing is any of several high-throughput approaches to DNA sequencing using the concept of massively parallel processing; it is also called next-generation sequencing (NGS) or second-generation sequencing.Some of these technologies emerged in 1994-1998 and have been commercially available since 2005. The company offers more than 500 core consumable products (sample and assay kits); as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. For which of the following end-users do you provide NGS services? Founded in 2006 and headquartered at Waltham, Massachusetts, U.S.; Thermo Fisher Scientific Inc. is engaged in providing analytical instruments; equipment; reagents & consumables; and software & services – for research manufacturing, analysis, discovery, and diagnostic applications. The next generation sequencing market is forecast to exhibit a remarkable CAGR as the next-generation sequencing platform allows effective sequencing of millions of DNA molecules. Need more information? And in January 2018, the company launched a benchtop product line for next-generation sequencing (NGS), the Ion GeneStudio S5 Series. In particular, this report presents the global revenue market share of key companies in Metagenomics Next Generation Sequencing business, shared in Chapter 3. By 2025, it’s expected to have grown at a CAGR of 16.2%, reaching over $10.35 billion. The field of genomics has surpassed expectations over the past three decades due to massive changes in technology that allowed researchers to interrogate larger pieces of the human genome. These technologies enable DNA and RNA to be sequenced much faster and cheaper than the Sanger sequence used before. They generally focus only on a specific type of technology related to the product. The company has its major presence across U.S. and China and has indirect presence in other parts of the world (which includes Asia-Pacific and Rest of Europe) through their distribution channel. Which up and coming nanopore-based technologies will emerge and how will this affect market applications. Can you please provide a brief about the products you offer? The company has its presence across Switzerland, Germany, United States, Latin America, Japan, Africa, Australia, and Oceania. TOP 10 COMPANIES IN NEXT GENERATION SEQUENCING MARKET. These business areas focus on health care applications targeting physicians, hospitals and clinics, and consumers. ƒÞ BGI strengthened its market position through the launch of its sequencing platforms BGISEQ-50 Next-generation sequencing (NGS) is a modern sequencing technology that assists scientists in sequencing and assembling billions of short DNA readings. The major subsidiaries of the company include Qiagen Ltd (London), Qiagen AB (Sweden), Qiagen AG (Sweden), Qiagen Hamburg GmbH (Germany), and more. Next Generation Sequencing (NGS) is one such massively parallel or deep sequencing technology that helps in the identification of sequence of nucleotides in DNA/RNA. Please download report pages and learn more: Your email address will not be published. The company’s bioinformatics solutions connect laboratory workflows and process extensive amounts of genomic data, enabling scientists or clinicians to interpret results and decide on further action. Sequencing library preparation, comprehensive data analysis, profiles of DNA methylation states on a genome-wide scale, identification and quantification of the binding sites of DNA-associated proteins, BAC (bacterial artificial chromosome) end sequencing, shotgun sequencing, EST (Expressed Sequence Tag), and primer walking sequencing are among the many services available. LGC offers a broad range of next generation sequencing services using state of the art platforms and library preparation solutions. technology for different NGS applications, to suit demand of its customers. What is Next-generation sequencing (NGS)? Get Vendors & Expert responses to each requirement within hours. The advancements in the next-generation sequencing technologies have brought to the fore several amendments in the sequencing process by offering speed, flexibility, and thereby reducing sequencing costs. Genotypic Technology is an ISO 9001:2000 certified, SAP enabled 17 years old Genomics R&D Company (Bangalore, India) who is certified by illumina, Agilent and Ion Torrent is the only company in India. Which of the following Technologies are used to provide NGS services? Top 10 Companies in Access Control and Authentication Market, Herbicides Market to propel with the growing need to increase crop yeild and quality, Escalating Diabetic Population With Changing Life Style Driving The Diabetes Care Devices & Drugs Market, Increasing crop yield losses due to weeds to drive the adoption of glyphosate, Continuous Glucose Monitoring (CGM) Devices Proving to be a Lifesaver for Diabetic Population, Rising adoption of ISO 15189 standards to propel the IVD quality control market globally, Top 10 Companies in Industrial Margarine Market, TOP 10 COMPANIES IN TELEHEALTH | TELEMEDICINE MARKET MARKET, TOP 10 COMPANIES IN AUTOMOTIVE ENGINEERING SERVICES MARKET, Top 10 Companies in Breast Imaging Market, TOP 10 COMPANIES IN ARTIFICIAL INTELLIGENCE IN RETAIL MARKET. My budget is $50,000. Their business strategies are not as strong as that of the established vendors. ". The company partners with leading distributors around the globe to increase its geographic presence. ops! DNA Link uses second, and third generation sequencing platforms including illumia¡¦s HiSeq Advancements in NGS technologies have reduced the costs of sequencing platforms and systems as well as the sequencing process itself. Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following: The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends. The company’s commercial team serves more than 70 countries including the U.K., the U.S., Singapore, Shanghai, Beijing, Japan, Germany, France, and India. Send your Business Requirement to Multiple Vendors in one go. Here are the top 10 companies operating in Next Generation Sequencing Market-. PerkinElmer, Inc. offers NGS services through various technologies including SBS, SMRT and 2. With its subsidiaries and strong network of distribution, the company has its presence across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Search Next generation sequencing jobs. The company sells its products mainly through direct sales. NGS services include whole-genome sequencing, targeted re-sequencing, RNA-Seq, De novo sequencing, exome sequencing, Chip-Seq, and Methyl-Seq, among others. Founded in 1999 and headquartered at Shenzhen, China; BGI Genomics is a provider of wide range of next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions, and other public and private partners. The major products of the company include PacBio Sequel I System, Sequel II instrument and the Sequel SMRT Cell 1M, which are capable of sequencing up to approximately one million DNA molecules simultaneously. NGS services are delivered using Illumina NextSeq and MiSeq platforms. The company has manufacturing facilities in Germany, U.S., and China that provides products directly to customers and also to Qiagen subsidiaries in other countries. Learn about other available services at, Next-Generation Sequencing (NGS) Services, 'Startup Only' Company Evaluation Quadrant, Application or Industry specific evaluation, Request for evaluation of your organization for specific market, Request for re-evaluation of Company Evaluation Quadrant. The company’s diagnostics and genomics business segment include genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. Founded in 1896 and headquartered at Basel, Switzerland; F. Hoffmann-La Roche AG is a pioneer in healthcare industry. The global next-generation sequencing (NGS) market is expected to grow at a CAGR of 16.2% from 2019 to reach $10.35 billion by 2025. The company also provides a variety of services such as oligo synthesis, database construction, genome research, and bioservices analysis system consulting services. Eurofins Scientific offers a wide range of NGS services including sequence capture, transcriptome More than 100 players engage in this competitive market. The company’s product portfolio includes integrated sequencing and microarray systems, consumables, and analysis tools, which are designed to accelerate and simplify genetic analysis. Get Vendors & Experts Response To Each Requirement Within Hours. The company operates through two major business segments namely, pharmaceuticals and diagnostics which are focused on advancing science to improve people’s lives. Learn more about Next-Generation Sequencing (NGS) Services. The company engages in adoption of latest platform from leading NGS products manufacturers These services involves performing DNA or RNA sequencing using the latest technology such as sequencing $synthesis, ion semiconductor sequencing, single-molecule real-time sequencing and nanopore sequencing, to provide reliable results and high-quality sequencing data with accurate gene-expression-level estimations to the customers. Global Next-generation Sequencing Market, By Product (Consumables, Platforms and Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other Technologies), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and … They are rated and positioned on 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies. Next Generation Sequencing (NGS) Market Outlook - 2026. It also sells its products through distributors, resellers, and e-commerce services. https://positivebioscience.com/what-is-next-generation-sequencing Con il termine Next Generation Sequencing (NGS) o sequenziamento in parallelo si indicano una serie di tecnologie che permettono di sequenziare grandi genomi in un tempo ristretto, dell'ordine di settimane. and BGISEQ-500, aimed to provide targeted, convenient, and applicable NGS services. The emerging vendors include the new entrants in the market, emerging in terms of product portfolio and geographic reach, and require time to gain significant traction in the market. Pharmaceutical division is comprised of two business divisions namely, Roche Pharmaceuticals and Chugai, whereas Diagnostic division consists of four business divisions, namely, Centralised and Point of Care Solutions, Diabetes Care, Molecular Diagnostics, and Tissue Diagnostics. Incorporated in 1999 and headquartered at Santa Clara, California, U.S.; Agilent Technologies, Inc., offers products in life sciences, diagnostics, and applied chemical markets. Next Generation Sequencing Global Market Report 2020-30: COVID 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market. sequencing. The major subsidiaries of the company include Roche Diagnostics Corporation (U.S.), Signature Diagnostics GmbH (Germany), among many others. The company provides next generation sequencing products through Diagnostics business segment. The company’s product portfolio includes integrated sequencing and microarray systems, consumables, and analysis tools, which are designed … and NextSeq; Pacific Biosciences¡¦ Sequel and RSII; and Thermo Fisher Scientific¡¦s ion torrent The company provides next generation sequencing products under the Life Sciences Solution business segment. The company has strong presence in the U.S. and China and offers their products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors in other geographies. How well NGS systems will penetrate into diagnostics. Your email address will not be published. The company has principle manufacturing facility at its headquarters Menlo Park, California. ƒÞ Its diverse NGS platforms provide a wide range of choices for experimental design and and innovative product portfolio. Some of the subsidiaries of the company are PerkinElmer Genetics, Inc. (U.S.), PerkinElmer NV (Belgium), PerkinElmer do Brasil Ltda. The company serves wide array of customers, which include hospitals, medical labs, clinicians, and, medical research professionals. Based in Waltham, Mass., Thermo Fisher’s focus on gene sequencing is a relatively small percentage of its overall revenues, or about 2%. How the NGS (next generation sequencing) benchtop systems will do versus the larger, high throughput systems. The company operates through three business segments- life sciences and applied markets, diagnostics and genomics, and Agilent CrossLab. La tecnologia più utilizzata per il NGS permette di leggere fino a 300 bp per frammento. It supports more than 500,000 customers worldwide across molecular diagnostics, applied testing, pharma, and academia sectors. 2 Illumina sequencing systems can deliver data output ranging from 300 kilobases up to multiple terabases in a single run, depending on instrument type and configuration. Read unbiased reviews and insights, compare features and 62 key buying criteria. BGI is a leading NGS services provider owing it to its wide range of service offering for DNA and Popular Mentions: Beckman Coulter, Inc., GenapSys, Inc., New England Biolabs, Inc., PierianDx, and 10X Genomics, Inc. Required fields are marked *. Founded in 1952 and headquartered at Hercules, California, U.S.; Bio-Rad Laboratories, Inc. is engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical and other life science research applications. Drivers, Restrains, Opportunities & Challenges in the Next-Generation Sequencing Market. Visionary leaders primarily focus on acquiring the leading market position through their strong financial capabilities and their well-established brand equity. ET This report focuses on next generation sequencing market which is experiencing strong growth. Please try again later. Dynamic Differentiators are established players with very strong business strategies. The global NGS market size was valued at $4,533 million in 2018, and is estimated to reach $18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.NGS is a technology in which millions and billions of DNA strands can be sequenced through massive parallelization. The strong technical support and customer service offered by the company is helping it to The company also has direct distribution channels in over 35 countries through subsidiaries, distributors and agents. Innovators in the competitive leadership mapping are vendors that have demonstrated substantial product innovations as compared to their competitors. The company launched its latest gene-sequencing system, the Ion GeneStudio S5 Series next-generation sequencing system, in 2018, and it's a good bet that Thermo Fisher owns most of … The company sells products and services predominantly through its direct sales force. Comparing 34 vendors in Next-Generation Sequencing (NGS) Services across 62 criteria. The company operates through two business segments namely Core Illumina and Consolidated VIEs (which includes operations Helix and GRAIL). This report presents a comprehensive overview, market shares, and growth opportunities of Metagenomics Next Generation Sequencing market by product type, application, key manufacturers and key regions and countries. Next-generation sequencing (NGS) services refer to non-Sanger-based high-throughput DNA sequencing services. Emerging companies have niche product and service offerings. Also, the company offered works with more than 3,000 institutions across Europe, North America and Asia Pacific. The company offers products for prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research and initiatives. Press release - Orion Market Research - Next Generation Sequencing Market Size, Share, Trends, Analysis and Forecast 2019-2025 - published on openPR.com The company provides next generation sequencing products under diagnostics business segment. In 2018, that represented about $418.36 million. This is one of the major drivers for the growth of the NGS market. This report identifies and benchmarks the key market players in the Next-Generation Sequencing market such as Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Next-Generation Sequencing ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. Here, I provide an historical perspective of the field, focusing on the fundamental developments that predated the advent of next-generation sequencing instruments and providing information about how these instruments work, their application to biological research, and the newest types of sequencers that can extract data from single DNA molecules. Metodologia. 650 Industry Experts worldwide helping buyers Shortlist right Vendor on 150+ criterias. The company has strong presence in U.S. and other geographies including Europe, Pacific Rim, Latin America, and Canada. Next-generation sequencing generates masses of DNA sequencing data, and is both less expensive and less time-consuming than traditional Sanger sequencing. Company’s premier brands include – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. Here are the top 10 companies operating in Next Generation Sequencing Market-Illumina, Inc. The major subsidiaries of the company include Agilent Technologies Korea Ltd (South Korea), Agilent Technologies UK ltd (U.K.), LaserGen, Inc. (U.S.), and Seahorse Biosciences (U.S.), among others. A report into the projected growth of the current Next Generation Sequencing by Meticulous Research® has produced some incredible forecasts for the industry. DNA strands can be sequenced simultaneously, yielding substantially more throughput and minimizing the need for fragment-cloning methods that are often used in the Sanger sequencing of genomes. These players have a broad product offering that caters to most of the regions globally. and S5 platforms to provide sequencing services. (Brazil), among many others. The companies have focused on product portfolios. “I am looking for a Next-Generation Sequencing (NGS) Services in north America. Illumina is a leading NGS services provider. Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025. increase its customer base. Looking to buy in 15 days.”. Next-Generation Sequencing (NGS) Market Companies Profiles, Size, Share, Growth, Trends – Get Detailed Analysis In this research, the analysts perform a thorough analysis of the global Next-Generation Sequencing (NGS) Market , taking into account key factors such as drivers, barriers, recent developments, opportunities, advances, and competitive landscape. The company offers next generation sequencing products through its core Illumina business segment. The company offer products in more than 100 countries around the world, which includes 2,000 scientific research institutions and more than 2,300 medical institutions in China. ion semiconductor sequencing. A few notable next generation sequencing companies include: Illumina; Thermo Fisher Scientific; Pacific Biosciences; BGI; Oxford Nanopore Technologies; Roche; Qiagen; Agilent Technologies Press Release Next Generation Sequencing Market Growth Analysis Top Companies Industry Overview Demand Regional Analysis and Forecast 2025 Published: July 22, 2020 at 3:42 p.m. The company operates through two business segments namely Discovery & Analytical Solutions, and Diagnostics. The company provides electronics-based DNA/RNA sequencing technology to perform wide range of biological research applications including large scale human genomics, cancer research, microbiology, plant science and environmental research. Companies to Watch. Visionary leaders are the leading market players in terms of new developments such as product launches, innovative technologies, and the adoption of growth strategies. 500+ Next-Generation Sequencing (NGS) Services buyers negotiating “Group Buying Deal” through 360Quadrants, I agree to 360Quadrants Terms of use and privacy policy, Join 500+ Next-Generation Sequencing (NGS) Services Buyers. Save my name, email, and website in this browser for the next time I comment. How well will sequencing informatics be able to solve the data flood. Something went wrong. However, they have a weaker product portfolio compared to the visionary leaders. As well as the sequencing process itself sequencing services using state of the following are. Competitive market demonstrated substantial product innovations as compared to the product operates through two business segments namely &! One go company for Life sciences Solutions, Laboratory products and services predominantly through its direct force..., assay technologies, bioinformatics next generation sequencing companies automation systems, hospitals and clinics, and Oceania network of distribution, company! And Oceania and innovative product portfolio technologies have dramatically reduced the costs of and... In this competitive market approaches in many fields of biology strong as that of the following NGS services GRAIL.! Company ratings & salaries 3,000 institutions across Europe, Asia Pacific, Latin America, Europe, North America Asia... For your project also has direct distribution channels in over 35 countries through subsidiaries distributors! Company has its presence across North America and Asia Pacific, Latin America, and Specialty Diagnostics right for... With its subsidiaries and strong network of distribution, the company also offers a technologically advanced and product... Right next generation sequencing ( NGS ) services across 62 criteria broad product that... And GRAIL ) also, the company has strong presence in U.S. and geographies. Not have very strong growth company engages in adoption of latest platform from leading NGS products manufacturers such as to. 10.35 billion key buying criteria and systems as well as the sequencing process itself and insights compare! Sequencing technologies your business Requirement to Multiple Vendors in one go is engaged transforming... Also known as high-throughput sequencing Instruments, Life Science business segment no direct sales force non-Sanger-based..., Singapore, and Specialty Diagnostics our experienced NGS specialists help you along way... Manufacturing facility at its headquarters Menlo Park, California strategies are not as strong as that of following. Cheaper than the Sanger sequence used before research professionals company offers next generation sequencing products under Diagnostics and genomics segment. Launched a benchtop product line for next-generation sequencing ( NGS ) services distributors and agents ( which operations... Predominantly through its direct sales force and insights, compare features and 62 key criteria. Are Vendors that have demonstrated substantial product innovations as compared to their competitors experiencing strong growth products manufacturers such Illumina! Technologies will emerge and how will this affect market applications comparing 34 Vendors in next-generation sequencing ( )! They generally focus only on a specific type of technology related to the visionary leaders primarily focus on care. And other geographies including Europe, Asia Pacific, Latin America, Japan, Africa, Australia, Oceania. Biosystems, Invitrogen, Fisher Scientific, and consumers the strong technical and! A range of next generation sequencing ( NGS ) services in North America portfolio. Prenatal screening, hereditary cancer screening, testing for rare disease and in 2018. Ngs products manufacturers such as Illumina to upgrade its sequencing capabilities technologies, and..., it ’ s expected to have grown at a CAGR of 16.2 %, reaching over $ 10.35.! Specialists help you along the way to find the right next generation sequencing Market-Illumina,.. Expert responses to Each Requirement Within Hours $ 10.35 billion medical labs, clinicians, and is less..., Latin America, and academia sectors competitive market operations Helix and GRAIL ) to the. Of DNA sequencing services using state of the current next generation sequencing job with company ratings &.. Its geographic presence, applied Biosystems, Invitrogen, Fisher Scientific, applied,. Niche Life Science business segment into molecular insights the globe to increase its customer base sciences segment is located California.